Cell Signaling Technology

PTMScan® Mono-Methyl Arginine Motif [mme-RG] Kit

#12235 · $2,540

100
Citing papers
6.2k
Combined citations
Supplier page Find this product

Research areas

Sirtuins and Resveratrol in Medicine11Autophagy in Disease and Therapy9Epigenetics and DNA Methylation6Cancer-related Molecular Pathways6Extracellular vesicles in disease5MicroRNA in disease regulation5Adipose Tissue and Metabolism5Cancer-related gene regulation5

Papers citing this product

1
TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
The EMBO Journal·2007·569 cit.·DOI
2
SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability
Nature Communications·2016·389 cit.·DOI
3
Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
Journal of Biological Chemistry·2009·312 cit.·DOI
4
Mechanical cell competition kills cells via induction of lethal p53 levels
Nature Communications·2016·220 cit.·DOI
5
Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth
Nature Communications·2021·184 cit.·DOI
6
Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells
Journal of Biological Chemistry·2008·172 cit.·DOI
7
Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2
Journal of Experimental & Clinical Cancer Research·2017·164 cit.·DOI
8
SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer
Protein & Cell·2020·154 cit.·DOI
9
Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells
BMC Cancer·2008·134 cit.·DOI
10
PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy
Oncogene·2017·133 cit.·DOI
PTMScan® Mono-Methyl Arginine Motif [mme-RG] Kit — Evidence — PubIndex